Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 2% Lidocaine for Symptomatic Hemorrhoids
NCT01961739Phase 3Unknown
- Sponsor
- Dubrava University Hospital
- Start
- Oct 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in Hemorrhoids (2 arms), sponsored by Dubrava University Hospital. Primary endpoint: Change in CORRECTS scale at 15 days. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT01961739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961739.